Azenta, Inc.'s revenue has shrunk 0.88% a year over three years, and grown 4.8% a year over five. Revenue growth, 3-year annual rate: −0.88% (Medical Instruments & Supplies median +9.4%). Revenue growth, 5-year rate: +4.8%, growth has slowed since the five-year average. Years of annual history on file: 17, FY2009 to FY2025, as filed.

AZTAAzenta, Inc.

Healthcare

$36.48+16% 1Y

$36.48

$16.0252 weeks$42.76

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−24.5 points).

1 to watch, 1 neutral, 1 without data

Revenue trend+5% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +5% a year.

Margin direction−24.5 points operating

Trailing-twelve-month operating margin, -30.2% now against -5.7% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbehind 83% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is AZTA growing?

Azenta, Inc.'s revenue has shrunk 0.88% a year over three years, and grown 4.8% a year over five.

−0.88%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.4% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +4.8%
Revenue growth, 5-year rate · −0.88% over three · growth has slowed since the five-year average
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›